dalteparin has been researched along with Cholangitis, Sclerosing in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thalheimer, U | 1 |
| Triantos, CK | 1 |
| Samonakis, DN | 1 |
| Zambruni, A | 1 |
| Senzolo, M | 1 |
| Leandro, G | 1 |
| Patch, D | 1 |
| Burroughs, AK | 1 |
1 other study available for dalteparin and Cholangitis, Sclerosing
| Article | Year |
|---|---|
A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood.
Topics: Adult; Aged; Anticoagulants; Artifacts; Blood Specimen Collection; Cholangitis, Sclerosing; Citrates | 2008 |